Literature DB >> 21414844

Why did maribavir fail in stem-cell transplants?

David R Snydman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21414844     DOI： 10.1016/S1473-3099(11)70033-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  9 in total

Review 1.  The biology of cytomegalovirus drug resistance.

Authors:  Morgan Hakki; Sunwen Chou
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

2.  Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.

Authors:  Justin M Reitsma; Scott S Terhune
Journal:  Antiviral Res       Date:  2013-09-23       Impact factor: 5.970

3.  CMV viral load kinetics as surrogate endpoints after allogeneic transplantation.

Authors:  Elizabeth R Duke; Brian D Williamson; Bhavesh Borate; Jonathan L Golob; Chiara Wychera; Terry Stevens-Ayers; Meei-Li Huang; Nicole Cossrow; Hong Wan; T Christopher Mast; Morgan A Marks; Mary E Flowers; Keith R Jerome; Lawrence Corey; Peter B Gilbert; Joshua T Schiffer; Michael Boeckh
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

4.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

Review 5.  CMV in Hematopoietic Stem Cell Transplantation.

Authors:  Rafael de la Cámara
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-06-20       Impact factor: 2.576

6.  Human cytomegalovirus and transplantation: drug development and regulatory issues.

Authors:  Megan McIntosh; Benjamin Hauschild; Veronica Miller
Journal:  J Virus Erad       Date:  2016-07-01

7.  Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients.

Authors:  Jacqueline M McBride; Daniel Sheinson; Jenny Jiang; Nicholas Lewin-Koh; Barbara G Werner; Jennifer K L Chow; Xiaoning Wu; Jorge A Tavel; David R Snydman
Journal:  Open Forum Infect Dis       Date:  2019-01-14       Impact factor: 3.835

Review 8.  Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.

Authors:  Morgan Hakki
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 4.213

9.  The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.

Authors:  Depeng Wang; Gang Li; Martin Schauflinger; Christopher C Nguyen; Ellie D Hall; Andrew D Yurochko; Jens von Einem; Jeremy P Kamil
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.